Daiwa Securities Group Inc. - MADRIGAL PHARMACEUTICALS INC ownership

MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 138 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of MADRIGAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$10
-37.5%
690.0%0.00%
Q2 2023$16
-5.9%
690.0%0.00%
Q1 2023$17
-15.0%
690.0%0.00%
Q4 2022$20
-99.5%
69
+21.1%
0.00%
Q3 2022$4,0000.0%570.0%0.00%
Q2 2022$4,000
-33.3%
570.0%0.00%
Q1 2022$6,000
+20.0%
570.0%0.00%
Q4 2021$5,0000.0%570.0%0.00%
Q3 2021$5,000
+66.7%
57
+96.6%
0.00%
Q2 2021$3,0000.0%290.0%0.00%
Q1 2021$3,0000.0%290.0%0.00%
Q4 2020$3,000290.00%
Other shareholders
MADRIGAL PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
HealthCor Management, L.P. 1,402,250$93,614,0004.00%
Parkman Healthcare Partners LLC 30,000$2,003,0000.93%
ARMISTICE CAPITAL, LLC 216,000$14,420,0000.89%
Avoro Capital Advisors LLC 349,000$23,299,0000.79%
Rock Springs Capital Management LP 250,000$16,690,0000.69%
Capital Impact Advisors, LLC 24,351$1,626,0000.68%
Baker Brothers Advisors 1,499,212$100,087,0000.62%
EWG Elevate Inc. 11,086$740,0000.56%
SHIKIAR ASSET MANAGEMENT INC 12,000$801,0000.54%
DAFNA Capital Management LLC 13,600$908,0000.38%
View complete list of MADRIGAL PHARMACEUTICALS INC shareholders